Altre lingue ProstaLund AB

Azioni

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 17:11:26 17/05/2024			Variaz. 5gg	Var. 1 gen.
0,654 ^SEK	-4,39%		-43,62%	-59,88%

16/05	ProstaLund AB (publ) riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
08/04	ProstaLund AB (Publ) presenta due nuovi studi con il catetere Schelin	CI

ProstaLund AB - Interim report January-March 2024	16/05
ProstaLund AB Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05
ProstaLund hosted unannounced audit by TÜV SÜD	12/04
Two new studies with ProstaLund´s Schelin Catheter® presented at EAU24 in Paris	08/04
ProstaLund AB Presents Two New Studies with Schelin Catheter	08/04
Schelin Catheter® - new study confirms efficiency and ease of use	27/02
Year-end report – ProstaLund AB (publ)	16/02
ProstaLund AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02
New agreement - Esbjerg Hospital starts up with CoreTherm® treatments	12/12
ProstaLund Signs an Agreement on Coretherm®? with the New Customer Sydvestjysk Sygehus	12/12
Interim report - ProstaLund AB (publ)	07/11
ProstaLund AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11
Schelin Catheter® has had its premiere in France.	11/09/23
ProstaLund AB Announces its Schelin Catheter Premiere in France	11/09/23
Schelin Catheter® beneficial together with TURP	05/09/23
ProstaLund signs sales agent agreement for France	31/08/23
Prostalund Signs Sales Agent Agreement for France	31/08/23
Patent has been approved in China	15/08/23
ProstaLund AB Receives the Positive News on Utility Model Application for Their Product CoreFlow Soft Stent	15/08/23
ProstaLund AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	25/07/23

Non ci sono risultati per questa ricerca